Harms of Intermittent vs Continuous Androgen-Deprivation Therapy for Prostate Cancer
- PMID: 26720183
- DOI: 10.1001/jamaoncol.2015.4682
Harms of Intermittent vs Continuous Androgen-Deprivation Therapy for Prostate Cancer
Comment on
-
Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer.JAMA Oncol. 2016 Apr;2(4):453-61. doi: 10.1001/jamaoncol.2015.4655. JAMA Oncol. 2016. PMID: 26720308 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
